RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Hybrid drug combination: Anti-diabetic treatment of type 2 diabetic Wistar rats with combination of ellagic acid and pioglitazone.

Hybrid drug combination: Anti-diabetic treatment of type 2 diabetic Wistar rats with combination of ellagic acid and pioglitazone.

Add to Collection
2017 Dec 15 Others RP Nankar, M Doble - Phytomedicine, 2017 - Elsevier

Full Author : ['Nankar, Rakesh P', 'Doble, Mukesh']
Journal Title : Phytomedicine : international journal of phytotherapy and phytopharmacology
Chapter : Section3
Journal Year : 2017
Cited by : 45.0

BACKGROUND: Pioglitazone is an effective drug for the treatment of type 2 diabetes. The drug was suspended from Indian market in June 2013 due to the risk of bladder cancer but was reintroduced in July 2013 because its benefits outweighed the risks. The r..... Read More

Keywords : ["hybrid drug combination antidiabetic treatment", "type diabetic wistar rat", "ellagic acid", "combination", "pioglitazone"]
PubMed Link : https://www.sciencedirect.com/science/article/pii/S094471131730154X
Google Scholar Link : https://scholar.google.com/scholar?cites=5850664894670689391&as_sdt=5,47&sciodt=0,47&hl=en&num=20